Innovation and Opportunities in Pediatric Therapeutic Development

Ther Innov Regul Sci. 2019 Sep;53(5):564-566. doi: 10.1177/2168479019869754.

Authors

Susan McCune¹, Ronald J Portman²

Affiliations

¹ Office of Pediatric Therapeutics, Office of Clinical Policy and Programs, Office of the Commissioner, U.S. Food and Drug Administration.
² Pediatric Development, Science and Innovation, Pediatric Center of Excellence, Clinical Development & Analytics, Novartis Pharmaceuticals Corporation.

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Child
Drug Development / methods*
Drug Dosage Calculations
Drug Therapy
Humans

Grants and funding

FD999999/ImFDA/Intramural FDA HHS/United States